| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.22 | 1e-06 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.22 | 3e-06 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.16 | 0.0006 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.16 | 0.0009 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.16 | 0.002 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.1 | 0.04 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.089 | 0.07 |